Skip to search.
 FTSE 100 Up 0.41%

Abbott Laboratories (ABT)

-NYSE
50.69 Down 0.08(0.16%) 31 Jul 21:03
|After Hours: : 50.67 Down 0.02 (0.04%) 31 Jul 22:54
Add to Portfolio
Prev Close:50.77
Open:51.07
Bid:50.29 x 200
Ask:51.55 x 200
1y Target Est:53.34
Beta:1.24
Earnings Date:20 Oct - 26 Oct (Est.)
Day's Range:50.60 - 51.13
52wk Range:39.28 - 51.74
Volume:5,573,486
Avg Vol (3m):4,936,560
Market Cap:75.47b
P/E (ttm):17.03
EPS (ttm):2.98
Div & Yield:0.96 (1.90%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABTDown 0.16%75.47b
NSRGYUp 0.47%239.53b
RHHBYUp 0.17%245.91b
TEVADown 0.07%58.53b

Key Statistics

Forward P/E (1 yr):20.95
P/S (ttm):3.69
Ex-Dividend Date:13-Jul-15

Analysts

Annual EPS Est (Dec-15) :2.16
Quarterly EPS Est (Sep-15) :0.54
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):2.46

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency; irritable bowel syndrome; int... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback